Silica as an Anti-Settling Agent: How It Keeps Pigments and Fillers Suspended

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: How to Request a Silica Quote: Information Suppliers Need for Accurate Pricing
  • Keywords: silica supplier Middle East
  • Published: 2026-11-20 10:37:13
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals

Angular Silica Powder: Properties, Uses and When to Choose It Over Spherical Silica

Does Silicon Dioxide Conduct Electricity? Why SiO₂ Is an Insulator
Foundry Silica Sand: AFS Grain Fineness, Specifications and Uses
44. Trzeciak K., Chotera-Ouda A., Bak-Sypien I.I., Potrzebowski M.J. Mesoporous silica particles as drug delivery systems - The state of the art in loading techniques and the recent progress in analytical approaches for monitoring these processes. Pharmaceutics. 2021;13:950. doi: 10.3390/pharmaceutics13070950. [ DOI ] [ PMC free post ] [ PubMed ] [ Google Scholar ]
Silica Surface Area Explained: Typical BET Values by Type and Why It Matters
This supports that the release rate depends on several components, among others, influenced by the pore size, the pore structure, the amount of drug loaded, the solubility of the API, and the resulting interaction between the carrier and the transported molecules [ 2 ]. By modifying these, the release kinetics can be controlled to a small extent, but a considerable influence can only be attained by surface functionalization of the mesopores. The following table contains some experimental data in terms of drug release in case of the previously shown APIs ( Table 2 ).
Silicone vs Silica: What Is the Difference and Where Is Each Used?
The skin is our largest organ, which consists of three layers: the epidermis, dermis, and hypodermis. Owing to its big surface zone, it also serves as an essential gateway for drug administration [ 25 ], which is fitting for both local (dermal) or systemic (transdermal) therapy [ 25, 56 ]. In spite of the popularity of this administration route, it is a challenge to get the API into deeper layers of the skin. The outermost layer of the epidermis, the stratum corneum, is the biggest hurdle to molecular penetration [ 25, 56 ]. However, the molecules must be absorbed through the capillaries of the dermis to achieve a systemic impact, which can be facilitated employing nanocarriers [ 56 ]. In addition, sweat glands or hair follicles can be effective alternative routes for the molecules to enter the deeper layers of the skin [ 25, 56 ]. In summary, it can be called as the transappendageal route. Among physicochemical properties, particle size is one of the most vital factors influencing absorption. Particles in the range between 200 and 300 nm are suitable for local treatment of the skin in diseases such as atopic dermatitis [ 25 ] since particles larger than 75 nm do not pass through the stratum corneum [ 25 ]. Smaller particles (approximately 50 nm) are suitable for systemic treatment [ 25 ], and on the whole, it can be said that nanoparticles with a diameter smaller than 25 nm can penetrate the skin most effectively, so they can be used for transdermal drug administration with an appropriate formulation [ 56 ]. By controlling the size of the nanocarrier, they penetrate to different depths in the skin. From the element of surface characteristics, cationic amino-functionalized MSNs show more efficient penetration into deeper layers of the skin than the particles with anionic surfaces of the same size [ 25 ]. The use of MSNs as a drug carrier may improve aqueous solubility, stability, and skin penetration of the drug [ 61 ]. In a research, gels containing MSN were prepared by employing distilled water to form the base, adding the gelling agent (Poloxamer 407), and adding HPMC to enhance the viscosity [ 83 ]. In another publication, MSN containing oleogels were prepared with sunflower oil and the addition of colloidal silicon dioxide as a gelling agent [ 61 ]. According to in vitro experiments, the gel matrix also affected the drug release kinetics [ 61, 83 ]. Slower drug release was observed in the case of gels containing loaded MSNs, compared to the free carriers, and the outcomes demonstrated close to zero-order release kinetics [ 61 ]. According to in vitro biocompatibility studies, this gel complex did not show any evidence of cytotoxicity on dermal fibroblast cells. Moreover, according to in vivo dermal safety studies, it has been proven that this preparation does not cause skin irritation during application, and so this formulation can be considered a safe product [ 61 ].

Silica for UV Adhesive: Rheology Control and Transparency Considerations

What is silica (SiO₂)?

silica for electronic encapsulation

What is the difference between fumed silica and precipitated silica?

silica for sale

What drives silica raw material prices?

fused silica vs quartz 38. Kheirkhah S., Abedi M., Zare F., Salmanpour M., Abolmaali S.S., Tamaddon A.M. Surface engineered palmitoyl-mesoporous silica nanoparticles with supported lipid bilayer coatings for high-capacity loading and prolonged release of dexamethasone: A factorial design approach. J. Drug Deliv. Sci. Technol. 2022;78:103943. doi: 10.1016/j.jddst.2022.103943. [ DOI ] [ Google Scholar ]

Cite this article: Silica Raw Materials News. "What Is an Antiblock Agent for Film? How Silica Prevents Film Blocking ." Published 2026-11-20 10:37:13. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.